PT - JOURNAL ARTICLE AU - Samuel A. Schueler AU - Lauren A. Gamble AU - Bryan F. Curtin AU - Samantha M. Ruff AU - Maureen Connolly AU - Cathleen Hannah AU - Martha Quezado AU - Markku Miettinen AU - Maureen George AU - Andrew M. Blakely AU - Jonathan M. Hernandez AU - Theo Heller AU - Christopher Koh AU - Jeremy L. Davis TI - Evaluation of Confocal Laser Endomicroscopy for Detection of Occult Gastric Carcinoma in <em>CDH1</em> Variant Carriers AID - 10.1101/2020.06.01.20118471 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.01.20118471 4099 - http://medrxiv.org/content/early/2020/06/03/2020.06.01.20118471.short 4100 - http://medrxiv.org/content/early/2020/06/03/2020.06.01.20118471.full AB - Background &amp; Aims Hereditary diffuse gastric cancer, attributed to inactivating germline CDH1 variants, is characterized by signet ring cell (SRC) morphology. We sought to evaluate the occult cancer detection rate using probe-based confocal laser endomicroscopy (pCLE) during endoscopic surveillance.Methods A prospective, single-institution study was conducted in asymptomatic adults with pathogenic or likely pathogenic (P/LP) CDH1 variants. Subjects received endoscopic gastric surveillance using pCLE in conjunction with the consensus Cambridge method (CM) of non-targeted mucosal biopsies. Systematic examination was performed with white light endoscopy (WLE) and pCLE. Abnormalities visualized by pCLE were biopsied, followed by non-targeted mucosal biopsies according to the CM. Pathologists were blinded to clinical and endomicroscopic findings. Primary endpoint was to determine pCLE sensitivity for detection of occult SRC carcinoma compared to CM.Results Thirty-six patients with P/LP CDH1 variants underwent endoscopy using pCLE and CM. Majority were female (75%) with median age 47 years. Median procedure time was 52.5 minutes, without serious adverse events. Targeted biopsies of focal abnormalities on WLE were negative for carcinoma. Overall, 19.4% (7/36) patients had SRC detected on ≥1 biopsy. Non-targeted CM biopsies revealed SRC in 11.1% (4/36), whereas pCLE revealed SRC in 16.7% (6/36). Fifteen patients, 5 of whom had SRC at endoscopy, underwent total gastrectomy; all 15 explants contained occult carcinoma. In those 15 patients, the false-negative SRC detection rates for pCLE and CM were 67% and 87%, respectively.Conclusions Confocal endomicroscopy alone has low sensitivity for occult cancer detection in CDH1 variant carriers. Reliable endoscopic surveillance is lacking as an alternative to prophylactic surgery in this high-risk population. (http://ClinicalTrials.gov, Number: NCT03648879).Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03648879Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT03648879 Funding StatementThis study was supported in part by the Intramural Research Program, National Cancer Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NCI Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesReasonable requests for data will be reviewed by the senior author.